← All trials
NCT00052195
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2001
- Primary completion
- Dec 1, 2008
- Completion date
- May 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 1975
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Dartmouth UniversityLead sponsor
- Dartmouth UniversityOverall official - principal investigator
- National Institute of Allergy and Infectious Diseases (NIAID)Collaborator
- Dartmouth UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.